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Executive Summary 
 
Stem cell transplantation has become an important process used to treat patients with 
bone marrow diseases. When implanted into patients, stem cells from the umbilical cord have 
been found to successfully proliferate as new neurons and glia, thereby improving the patients’ 
health.  Neurons and glia are imperative for the health and normal function of our nervous 
system. Neurons are electrically active cells that can produce action potentials to transmit signals 
based on electrochemical impulses. Glia, which comprise a large part of our nervous systems 
(90% of the brain alone), were once dismissed as mere padding in the nervous system.  However, 
it is now known that they are actually an integral component of the system, serving to facilitate 
and ensure the proper transmission of signals between neurons.  Damage to or loss of  neural 
cells, whether due to physical injury, removal (as in the case of cancer) or diseases such as Motor 
Neuron Disease (MND) and Parkinson’s disease is severely detrimental to one’s health.  Using 
current tissue engineering technology, stem cells harvested from the matrix of the umbilical cord 
(known as Wharton’s Jelly), may be differentiated into neurons or glia, effectively replacing 
those that were lost or damaged. To ensure biocompatibility, umbilical cord matrix cells from 
direct relatives are used. Therefore, cryopreservation of these cells is imperative to the stem cell 
treatment to be used in the future.  Our goal is to use FIDAP and GAMBIT software solutions 
and mesh to compare the effectiveness of glycerol, propylene glycol, and DMSO, three 
commonly used cryopreservatives, in order to determine the cryopreservation agent that will 
maximize viability of umbilical cord stem cells. 
 
 
 
Figure 1. Cross section of normal umbilical cord. 
Embedded within a spongy, proteoglycan rich matrix 
know as Wharton’s jelly (W) are normally two 
arteries (A) and one vein (V). 
Source: 
http://info.med.yale.edu/obgyn/kliman/Placenta/Arti
cles/EOR_UC/Umbilical_Cord.html 
 
 Design Objectives and Introduction 
 
  The purpose of our project is to compare the percent viability of umbilical cord tissue 
upon vitrification using three different cryopreservation agents (CPAs). Percent viability refers to 
the mass of tissue that survives the cryopreservation process per mass of total tissue used.  We 
will simulate cryogenic cooling with liquid nitrogen using maximum allowed concentrations of 
the CPAs dimethyl sulfoxide (DMSO), propylene glycol, and glycerol.  These maximum 
concentrations of each CPA come from prior research and are used with the assumption that they 
will yield lower cooling rates necessary to vitrify and thus are more beneficial to cell viability.   
 
  The axial-symmetric geometry is used to model umbilical cord tissue because the cord is 
assumed to be symmetric on both the x and y-axis.  This cylindrical cord tissue is 3.6 cm in 
diameter and has a concentric hollow tube concentric with a smaller 8 mm diameter to account 
for the single vein within the umbilical cord.  According to our model, the hollow cylindrical 
cord tissue is in contact with liquid nitrogen at –196C both on its inner (vein) and outer surfaces 
in their entireties.  Thus, the schematic is as follows: 
 
In order to develop our umbilical cord tissue cryopreservation model, a number of 
assumptions were made.  They were as follows: 
1.  Cryoprotectants are evenly distributed in the umbilical cord tissue. 
2.  Muscle tissue properties approximate stem cell properties. 
3.  No convective cooling. 
4. Constant  material  properties. 
5.  No heat generation. 
6.  Effects of cooling in umbilical arteries can be neglected. 
7.  The umbilical cord is symmetric. 
8.  Cooling rates to achieve vitrification are approximated by highest survivability data obtained from the 
literature. 
9.  The umbilical cord tissue is submerged in a large reservoir of liquid nitrogen with no fluid flow. 
10. The umbilical cord tissue is initially at room temperature. 
 
Once the cooling rates for ethylene glycol, DMSO, and glycerol are calculated, they can 
be compared with the survivability of umbilical cord tissue data obtained from the literature.  By 
our definition, cells are viable if they achieve 50% survivability.  This percentage is adequate 
because a culture can be grown to replenish the lost cells.  In consequence, the optimal 
cryopreservation agent can be determined with respect to maximization of umbilical cord stem 
cell preservation time.  The cooling rate profiles were found by using a function from FIPOST to create a FIOUT 
file.  This FIOUT file was a temperature-time history profile for each of our 20 nodes at the 
center of our mesh.  We found the cooling rates at each node by finding the slope of the time vs. 
temperature plot (between time 0 to time 105.1 sec).  From the time history plots (Appendix C), 
we can see that the cooling rates computed from these two times will be the initial (linear 
portion) cooling rate.  Furthermore, it is standard practice to submerge the umbilical cord in 
liquid nitrogen for slightly more than 60 seconds for cryopreservation.  These values were 
plotted against the node number using Microsoft Excel.  The critical cooling rates for each 
cryopreservant were obtained from the literature (see Appendix D).  These critical cooling rates 
were compared with our calculated cooling rate profiles to determine the portions of the 
umbilical cord, based on our mesh that will survive. 
 
Glycerol 
 
For 50% survivability, the cooling rate needs to be above 70 C/min (see Appendix D for 
data from literature).  Therefore, the nodes between 207 and 216 are not viable.  By taking the 
ratio of the volume of viable nodes (which is proportional to the square of the radius of the 
portion as obtained from the mesh) to the total volume of the model, we found that 12.76% of the 
sample achieves 50% survivability.   
 
DMSO 
 
  For 50% survivability, the cooling rate must be between 0.5C/min and 50C/min.  
Therefore, the nodes between 1064 and 1058 are viable.  Using the same formula as for glycerol, 
we found that 18.37% of the sample achieves 50% survivability.   
 
Propylene Glycol   
 
For 50% survivability, the cooling rate must be below 100C/min.  Therefore, the nodes 
between 65 and 72 are viable.  As a result, 73.9% of the sample achieves 50% survivability.   
 
For all three cryoprotectants in solution, we found that when the umbilical cord tissue 
was first immersed (t=2 seconds) in the –196 C liquid nitrogen, the three surfaces (top, right, 
inner) immediately cooled to a much lower temperature than the rest of the tissue. However, by 
the time 105 seconds had elapsed, the temperature drop was better distributed throughout the 
tissue with only the middle cylindrical shell not being as affected.  At the center of the umbilical 
cord (left side of the axis-symmetric model), we plotted the temperature of nodes 195 (glycerol), 
192 (DMSO), and 160 (propylene glycol) as a function of time.  From these plots, we saw that in 
all three cases, the temperature exponentially decays. (see Appendix C) 
 
 
 
Results and Discussion 
 
Cooling Rate Profiles for CPAs at centers 
 A.    14.3% Glycerol as cryoprotectant    B.  6.06% DMSO as cryoprotectant    C. 
7.86% Propylene Glycol as cryoprotectant 
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Cooling Rate Profile for DMSO
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Cooling Rate Profile for Propylene Glycol
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Viability of cells (red = living) due to  
 
A.    14.3% Glycerol as cryoprotectant    B.  6.06% DMSO as cryoprotectant    C. 
7.86% Propylene Glycol as cryoprotectant  
   
 
Sensitivity Analysis 
 
The sensitivity analysis showed that individually changing the density, thermal 
conductivity, and specific heat by 10% did not have a significant effect on the temperature-time 
profile.  Because of toxicity levels, only small concentrations of cryopreservation agents could 
be used.   As a result, the media had properties that were very similar to those of human tissue.  
Therefore, it can be concluded that the property values we obtained from the literature were 
accurate enough for our model. Refer to Appendix C for the figures. 
 
Our sensitivity analysis also showed that changing the concentrations of the 
cryopreservation agents did not have a significant effect on the temperature-time profiles.  When 
the concentrations of propylene glycol, DMSO, and glycerol in the umbilical cord tissue were 
increased by twenty percent, the temperature contours remained relatively constant.  Thus, using 
cryopreservant concentrations that were equal to the toxicity levels is sufficient for maximum 
survivability. 
 
 
Original temperature contour plot at t = 105 for 
Propylene Glycol 
After increasing the concentration of Propylene 
Glycol by 20%    
   
Original temperature contour plot at t = 105 for 
Glycerol 
After increasing the concentration of Glycerol 
by 20% 
   
 
 
Original temperature contour plot at t = 105 for 
DMSO 
 
 
After increasing the concentration of DMSO  
by 20%    
 
 
Because of the different properties of each CPA and their specific cooling rates that 
determine the survivability of tissue, we were unable to predict which cryoprotectant agent 
would yield the highest survivability before running our model.  However, because current 
studies seem to use DMSO more often than the others, it was though likely to be the optimal 
CPA for vitrification.  Our results showed that glycerol yielded the lowest percent survival 
(12.76%), then DMSO (18.37%), and propylene glycol yielded the highest percent survival 
(73.9%).  These results are shown graphically in the “Results and Conclusions” section.  We also 
constructed a model for the CPA ethylene glycol, but we were unable to find the relationship 
between the cooling rate and percent survivability of cells in any published literature.  Further 
study would be needed to make any conclusions.     
 
 
Conclusion and Design Recommendations 
 
Based on our analysis, propylene glycol gives the largest portion of umbilical cord tissue 
with 50% survivability out of the three cryopreservation agents.  Our model indicates that 73.9% 
of the cord tissue will be viable upon vitrification.   
 
Although our results were suitable for this project, there are some things that can be taken 
into consideration in the future if our project were to be refined.  The properties that were used in 
our governing equation were based on muscle tissue properties from published literature because 
those for umbilical cord tissue were unavailable.  Seeing that fetal tissue has some physiological 
differences to adult muscle tissue, using exact values for tissue properties could give a more 
precise result.   
 
We would also recommend that our design be improved by including the effects of 
cooling in the umbilical arteries.  The two arteries found in the umbilical cord tissue are small in 
diameter compared to the one large vein, but they could cause asymmetrical cooling in the tissue 
if liquid nitrogen were allowed to fill them.  In addition, the structure of the umbilical cord in real life would not be totally symmetric.  Therefore, to get more accurate results, the umbilical 
cord should be modeled in 3-D. 
 
For cost considerations, propylene glycol or glycerol would be the more inexpensive 
choices of the three cryoprotectants that we used.  They were listed as costing approximately $25 
and $29 respectively for 500 mL, compared to $41 for 500 mL of DMSO.  Because our model 
found that propylene glycol generated the highest percentage of cell viability, combined with its 
low price it is the best choice of cryopreservation agent for umbilical cord preservation.  
 
Another option in stem cell harvesting would be to cryopreserve the umbilical cord blood 
from the two arteries and the vein rather than the tissue itself.  Because it is more cost effective 
to preserve vials of a liquid instead of an entire sample of human tissue, it would be financially 
advantageous for researchers to work with umbilical cord blood rather than umbilical cord tissue.  
 
 
Appendix A: 
 
1. Geometry:  
 
 
 
 
 
 
 
 
 
 
2. Mesh: 
 
The axi-symmetric mesh to the right is a 
model of the cylindrical tissue of the 
umbilical cord.  The mesh was created 
using Gambit software. 
 
 
  
 
 
 
 
 
 
 
 
3. Governing equation: 
 
To model the cooling of our umbilical cord, the energy equation was used.  Because convection 
was not included in our study and heat was not generated, these terms were excluded from our 
governing equation.  
 
4. Boundary Conditions: 
 
The umbilical cord is assumed to be submerged in liquid nitrogen after the CPAs have been used 
in vitrification.  Liquid nitrogen is assumed to be at 77 K and this is the temperature at the 
boundaries: 
 
T top = T bottom = T right  = 77 K 
 
5. Initial Conditions: 
 
Assuming that the umbilical cord tissue is at room temperature, the initial condition is  
T = 294 K at t = 0. 
 
6. Properties 
 
To obtain our properties, we took a weighted average of the properties of each cryoprotectant 
and the properties of muscle tissue based on the percentage of cryoprotectant used. 
 Glycerol  DMSO  Propylene  glycol 
Ethylene 
glycol 
Mass Percentage used  
(toxic level (%))  14.28 6.06  9.30 
 
7.86 
Specific heat (J/kg-K)  3459.1908 3532.6506  3275.3730  3560.3214 
density (kg/m3)  1097.418 1072.7574  1067.2000  1071.5502 
conductivity (W/m-K)  0.4494 0.4593  0.4674  0.4591 
        
        
Dimensions (m)       
diameter after birth  0.036      
radius after birth   0.018      radius of vein  0.004      
length   0.3      
        
 
 
 
 
Appendix B 
 
PROBLEM command: 
Geometry Type – Axisymmetric (we used symmetry to model half of an umbilical cord 
(lengthwise) as a rectangle above the x-axis (to account for the hollow vein at the center) rotated 
about the x-axis) 
  
Flow Regime – Incompressible (there is no fluid flow in this problem) 
  
Simulation Type – Transient (we are modeling temperature changes with time) 
  
Convective Term – Linear (because there is no fluid flow, there is no nonlinear portion of the 
convective term) 
  
Momentum Equation – No Momentum (no fluid flow in this problem) 
  
Temperature Dependence – Energy Equation (we are modeling changes in temperature and 
therefore, the energy equation is used to model our system) 
  
  
  
SOLUTION command: 
S.S. – 10  
ACCF – 0  
  
We used the default values for a transient solution in our solution command.   
  
TIMEINTEGRATION command: 
  
Time Integration – Backward 
  
Number of Time Steps (Nsteps) – 1000 (Number of timesteps used to Obtain a solution) 
  
Starting Time (Tstart) – 0 (seconds) 
  
Ending Time (Tend) – 5400 (seconds) 
  
Time Increment (DT) – 0.001 (initial timestep increment) 
  Time Stepping Algorithm (Variable) – 0.001 (allows program to adjust timestep size to fit the 
solution) 
  
Increment Max (INCM) – 10 (limits the size of timestep increase to 10 seconds) 
 
 
Mesh Convergence 
 
There was no change in the temperature contour at the time of our interest (t = 1500) with an 
increased number of elements and increased grading of the mesh. Furthermore, the contour lines 
are smooth and not jagged. We conclude that our mesh has converged. (Refer to Appendix C for 
mesh / mesh convergence diagrams) 
 
 
Appendix C 
Meshes used for CPAs 
A.    14.3% Glycerol as cryoprotectant   B.  6.06% DMSO as cryoprotectant   C. 
7.86% Propylene Glycol as cryoprotectant 
     
   
 
 
 
 
 
 
 
Time History Plot at the center for CPAs 
A.    14.3% Glycerol as cryoprotectant   B.  6.06% DMSO as cryoprotectant    
C. 7.86% Propylene Glycol as cryoprotectant  
   
 
Temperature Contours at t = 2 seconds for CPAs 
A.    14.3% Glycerol as cryoprotectant   B.  6.06% DMSO as cryoprotectant    
C. 7.86% Propylene Glycol as cryoprotectant 
     
 
 
Temperature Contours at t = 105 seconds for CPAs 
A.    14.3% Glycerol as cryoprotectant   B.  6.06% DMSO as cryoprotectant    
C. 7.86% Propylene Glycol as cryoprotectant  
   
 
 
 
 
Sensitivity Analysis for Glycerol – History Plot at the Center 
   
Original density, thermal conductivity, and 
specific heat values 
Density, thermal conductivity, and specific heat 
values increased by 10% 
 
  
 
Sensitivity Analysis for DMSO – History Plot at the Center 
   
Original density, thermal conductivity, and 
specific heat values 
Density, thermal conductivity, and specific 
heat values increased by 10% 
 
 
 
 
 
 
 
Sensitivity Analysis for Propylene Glycol – History Plot at the Center 
   
Original density, thermal conductivity, and 
specific heat values 
Density, thermal conductivity, and specific heat 
values increased by 10% 
  
 
Mesh Convergence For Glycerol 
 
   
   
 
 
 
Mesh Convergence For DMSO 
    
   
 
 
Mesh Convergence For Propylene Glycol 
 
      
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix D:  
Source: Hunt et. al 
 
Source: Mazur 
 
Source: VILLALBA et. al 
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